Self-management of Anticoagulation Treatment

NCT02864537 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2016-08-12

No results posted yet for this study

Summary

The aim of the study was to compare self-management of anticoagulant treatment with conventional anticoagulant treatment in Norway.

Conditions

Interventions

OTHER

Training

Patients were trained to measure INR and dose warfarin

Sponsors & Collaborators

  • University of Bergen

    lead OTHER

Principal Investigators

  • Una Ø Sølvik, PhD · University of Bergen

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2013-03-31
Completion
2013-03-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02864537 on ClinicalTrials.gov